Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | SNRPA | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | MND1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | GPR1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | ZNF280C | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | SH3BP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | PRSS23 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |